Last10K.com

Integra Lifesciences Holdings Corp (IART) SEC Filing 8-K Material Event for the period ending Tuesday, April 21, 2020

Integra Lifesciences Holdings Corp

HISTORY TOOLS
CIK: 917520 Ticker: IART

View differences made from one to another to evaluate Integra Lifesciences Holdings Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Integra Lifesciences Holdings Corp.

Continue

Assess how Integra Lifesciences Holdings Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Integra Lifesciences Holdings Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Document And Entity Information
Ticker: IART
CIK: 917520
Form Type: 8-K Corporate News
Accession Number: 0000917520-20-000014
Submitted to the SEC: Tue Apr 21 2020 4:30:59 PM EST
Accepted by the SEC: Tue Apr 21 2020
Period: Tuesday, April 21, 2020
Industry: Surgical And Medical Instruments And Apparatus
Events:
  1. Event for Officers

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/iart/0000917520-20-000014.htm